If You Invested in CareCloud, Inc. (CCLD)

CareCloud, Inc. (Nasdaq: CCLD) is a healthcare technology company that focuses on AI-driven and technology-enabled solutions for medical practices, hospitals, integrated health systems, and healthcare organizations across the United States. The company is frequently described in its public disclosures as a leader in healthcare technology, generative AI solutions, and AI-powered platforms that help clients increase financial and operational performance, streamline clinical workflows, and improve the patient experience.

CareCloud’s offerings span revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence (BI), patient experience management (PXM), digital health, and artificial intelligence (AI). Across multiple news releases, the company notes that more than tens of thousands of providers rely on its solutions to improve patient care while reducing administrative burdens and operating costs.

Business focus and core solutions

According to the company’s descriptions in recent press releases, CareCloud delivers AI and technology-enabled solutions that support both ambulatory and inpatient care settings. Its platform is positioned to help clients improve financial results and operational efficiency by addressing clinical workflows, revenue cycle processes, and patient engagement.

The company highlights several core solution categories in its public materials:

• Revenue Cycle Management (RCM) – tools and services aimed at managing the financial aspects of care delivery and revenue cycle performance.
• Practice Management (PM) – solutions that support administrative and operational workflows in medical practices.
• Electronic Health Records (EHR) – clinical documentation and record-keeping systems for providers, including ambulatory and hospital environments.
• Business Intelligence (BI) – analytics capabilities that provide insights into operational and financial performance.
• Patient Experience Management (PXM) – tools designed to enhance patient interactions and overall experience.
• Digital health and AI – solutions that apply artificial intelligence and digital technologies to healthcare workflows, including phone-based patient access and analytics.

AI-driven innovation and stratusAI portfolio

CareCloud emphasizes AI as a central part of its strategy. The company has established an AI Center of Excellence, with dedicated teams driving product innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement. Public disclosures describe CareCloud as a provider of AI-powered and generative AI solutions for medical practices and health systems nationwide.

One example highlighted in recent news is stratusAI Desk Agent, described as an agentic AI phone receptionist designed to modernize and automate patient phone interactions. According to the company, stratusAI Desk Agent brings conversational AI into call center workflows to provide 24/7, no-wait phone access through autonomous, human-like AI conversations. It is designed to manage high-volume calls and complete front-desk and hospital patient access center workflows, including appointment scheduling and related tasks, within integrated EHR and PM environments.

CareCloud also refers to stratusAI Voice Audit as part of its AI suite, describing it as a conversational intelligence platform that provides call monitoring, quality scoring, and analytics on call volumes, service levels, and patient sentiment. Together, the stratusAI Desk Agent and stratusAI Voice Audit offerings are presented as forming an AI-powered phone ecosystem that gives practices and hospitals visibility into the patient phone experience and operational performance.

Expansion into hospital and inpatient software

In its recent communications, CareCloud notes that it has expanded from ambulatory markets into the hospital and inpatient software space. The company reports the acquisition of Medsphere Systems Corporation, a hospital IT business, and the acquisition of HFMA’s MAP App, a hospital benchmarking tool created by the Healthcare Financial Management Association (HFMA).

Medsphere’s emergency department information system (EDIS), branded Wellsoft, joined the CareCloud product portfolio through this acquisition. CareCloud describes Wellsoft as an emergency department information system that has been recognized by KLAS as a category leader in emergency medicine, including Best in KLAS for Emergency Department EHR in multiple years through 2020. The company states that Wellsoft provides an emergency-grade documentation platform and clinical workflow engine designed for rapid patient flow, elevated acuity, and streamlined documentation, and that it is being brought into the urgent care market through agreements with urgent care providers.

HFMA’s MAP App is described as a hospital benchmarking tool used by hospitals and healthcare organizations to measure and benchmark revenue cycle management performance. CareCloud’s public statements indicate that the acquisition of MAP App, combined with a long-term joint marketing agreement with HFMA, is intended to expand MAP App’s capabilities with AI-driven insights and accelerate its growth throughout the hospital market, complementing CareCloud’s AI-powered revenue cycle platform.

Client base and market reach

Across multiple press releases, CareCloud reports that more than 40,000 to 45,000 providers rely on its solutions. These providers include medical practices and health systems nationwide, as well as hospitals and integrated health systems that use CareCloud’s technology for revenue cycle management, EHR, analytics, and patient experience management.

The company describes itself as serving urgent care organizations, ambulatory practices, and hospital clients. For example, CareCloud highlights an agreement with Affinity Urgent Care, a multi-site provider of urgent care services in the Houston–Galveston region of Texas, which selected the Wellsoft emergency department information system to support its urgent care clinics.

Corporate developments and capital structure elements

CareCloud’s securities include common stock and preferred stock. The company’s disclosures reference its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, with the Series B Preferred Stock trading on the Nasdaq Global Market under the ticker symbol CCLDO. Public filings and press releases describe dividend policies, redemption features, and dividend payment schedules for these preferred shares.

The company has also reported transactions affecting its preferred stock, such as the mandatory conversion of Series A Preferred Stock into common stock and the resulting delisting of that preferred series from Nasdaq, as well as ongoing monthly cash dividends on Series B Preferred Stock and plans to address accumulated dividends in arrears through double monthly dividend payments funded from internally generated cash flow.

Growth strategy and acquisitions

In its earnings and conference-related communications, CareCloud discusses a growth strategy that includes acquisitions and AI initiatives. The company reports completing multiple acquisitions in a single year, including Medsphere and HFMA’s MAP App, and refers to these as transformative for its hospital market presence and revenue cycle capabilities.

CareCloud also highlights the role of its AI Center of Excellence in integrating AI into acquired platforms, with the stated goal of enhancing performance and efficiency and creating cross-sell and up-sell opportunities across its client base. Public statements describe the company as pursuing profitable growth, margin expansion, and increased recurring revenues, though specific financial figures and guidance are time-bound and subject to change.

Regulatory filings and listing status

CareCloud files periodic and current reports with the U.S. Securities and Exchange Commission (SEC), including Forms 8-K that disclose material events such as acquisitions, dividend announcements, earnings releases, and governance changes. For example, the company has filed 8-Ks describing the Medsphere acquisition, the acquisition of MAP App, dividend declarations on its preferred stock, and earnings results.

An 8-K filed in November 2025 notes that the company received a notice from the Nasdaq Stock Market regarding temporary non-compliance with certain board independence and audit committee composition requirements following the death of an independent director. The filing also states that CareCloud is entitled to a cure period under Nasdaq rules and that the board plans to regain compliance by appointing an additional independent director.